Are you a community provider who treats Veteran patients with opioid use disorder (OUD)? Are you concerned about opioid use during the pandemic?
You’re not alone! Join our Dec. 17 webinar on lifesaving medications for OUD along with VA initiatives that support community providers treating Veterans with OUD.
VHA is a national leader in in Opioid Overdose Education and Naloxone Distribution (OEND), and is committed to supporting access to lifesaving medications for opioid use disorder (MOUD). During this webinar, you’ll learn about resources available to support provision of lifesaving naloxone and MOUD to Veterans.
Target Audience(s): Community providers and healthcare teams
- Elizabeth Oliva, Ph.D., VA National Opioid Overdose Education and Naloxone Distribution (OEND) coordinator, VA Office of Mental Health and Suicide Prevention, and investigator, VA Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA.
- Joseph Liberto, MD, VA National Mental Health director, Substance Use Disorders, Office of Mental Health and Suicide Prevention, Baltimore, MD.
Date: Dec. 17 at 1 p.m. ET.
- Describe Opioid Use Disorder (OUD) and Medications for OUD (MOUD).
- Describe Opioid Overdose Education and Naloxone Distribution (OEND).
- Discuss relations between OUD, overdose and suicide.
- Describe specific interventions to address the relations between OUD, overdose and suicide.
Access: Register in VHA TRAIN. Webinar will be recorded and placed in VHA TRAIN for later viewing.
- AAPA: CME Credits
- AACME – Non-Physician AMA PRA Category 1 Credits
- ACPE – Contact Hours/Continuing Pharmacy Education (CPE) Credits
- ANCC: Contact Hours Continuing Nursing Education
- APA: Continuing Education Credit
- ASWB: Continuing Education Clock Hours
- Joint Accreditation for Interprofessional Continuing Education (JA IPCE)
- NYSED SW: Continuing Education Clock Hours
Over 260,000 Veterans have received naloxone from VA
VA has distributed lifesaving naloxone to over 260,000 Veterans with over 1,500 reported overdose reversals with naloxone. Although rates of MOUD are increasing, only a little more than 40% of patients with OUD in VHA receive such treatment, with substantial variation across VA facilities and patient characteristics.
This webinar is part of VA’s commitment to ensuring community providers and healthcare teams are aware of resources available to support provision of lifesaving naloxone and MOUD to Veterans.
Barbara Plantt is an outreach coordinator for the VHA Office of Community Care.